News
Neuralink shouldn’t solve Anxiety and Depression disorders
Neuralink aims to treat some of the most severe and damaging neurological diseases on Earth. In terms of Alzheimer’s, dementia, and epilepsy, a Neuralink device would be a great way to prevent these diseases from ruining everyday life for those who have been affected by them. With that being said, Neuralink needs not to treat anxiety and depression disorders, because those illnesses require human reaction and vulnerability to treat. Defeating anxiety and depression should be done without the help of a complete fix, and it is crucial not to look past the importance of humans being able to feel these two sensations.
This is something I feel very strongly about for several reasons.
Before I dive into those reasons, I want to explain why I feel qualified enough to take a stance that I think many supporters of Neuralink will disagree with.
I have dealt with clinical anxiety and severe depression for my entire life. I was clinically diagnosed in 2009 at the age of 14 with both of these disorders, and I would estimate that it took me around 11 and a half years of diligence on my part to begin living a normal life. My anxiety and depression disorders hindered me from doing a lot of things in my life: playing certain sports, moving away for college (on multiple occasions), keeping past jobs, committing to relationships, etc. It has affected me in the worst way for so many years, and I would never want anyone, even my worst enemy, to experience the things that I felt on a daily basis when I was under the control of these two diseases.
However, I don’t think that everyone should completely rid themselves of anxiety and depression. Why? Because they are two emotions, as humans, we need to have.
Anxiety, while painful and difficult to confront head-on, is necessary for some reasons. The first being the obvious, anxiety is an excellent way to sense when danger is near, and it is a crucial part of our fight or flight response. It can warn someone when there is an issue with what is going on near them and can be life-saving in certain circumstances.
Anxiety also is an opportunity to grow as a human being. Facing and confronting anxious thoughts is one of the best ways to test resilience and learn about what we are made of. Anxiety teaches us a lot about ourselves, and while frightening, facing it directly is one of the best ways to show that we can push through certain circumstances that we aren’t confident about.
-
This is a preview from our weekly newsletter. Each week I go ‘Beyond the News’ and handcraft a special edition that includes my thoughts on the biggest stories, why it matters, and how it could impact the future.
A big thanks to our long-time supporters and new subscribers! Thank you.
Depression, while more severe in my own experiences, also has its advantages. Without darkness, we wouldn’t know what light is. Without depression, we wouldn’t know about happiness. There are points where humans need to face adversity and challenging circumstances to feel the great things about life.
Now, the way I treated my anxiety and depression disorders was a clinically-focused approach. I regularly attended therapy sessions, took medication, and spoke to doctors as often as I could. While I wholeheartedly believe everyone should talk to a therapist at least three times a year, I disagree with taking medications. In my experience, they are a masking agent for anxiety and depression disorders, especially. They caused me more problems after I started taking them, and the side effects needed treatment on their own.
I believe the best way to treat disorders like anxiety and depression is solely up to the person who is dealing with them. When I started to make real progress with my issues, I began using Exposure Therapy to treat my problems. I did as many things as I could that scared me. This included long drives by myself, roller coasters, and doing more things independently. When I started doing these things, I had stopped taking medication, and my self-diligence started to solve the problems I was facing.
I am in no way condoning that medication is not a wrong way to initially treat these illnesses. However, I do not believe that the healthy dose of side effects that come as a result of taking these medications is helpful to anyone who is being treated for either disorder.
This is where my issue with Neuralink comes in.
-
I believe that Neuralink intends to completely remove these sensations from a person’s emotions, which I feel can be dangerous to the future. Taking away emotions from humans can be detrimental to the way people communicate with each other and respond to specific events. As hazardous and as stressful as dealing with any mental illness is, solving them requires a long and tiring fight. It is not easy, but anything in life that is worth doing rarely is.
I believe very strongly that removing emotions from humans is one of the most dangerous things that anyone could do. At what point will devices like Neuralink completely take over the human brain? When will emotions begin to disappear from people? Could it lead to a decreased amount of social interaction? How would that make us any different than robots?
It is dangerous, in my opinion, to remove core emotional responses from a human. Nobody wants to be depressed, and nobody wants to be anxious. But treating these diseases is done by finding out who we are as people. It requires us to go out of our comfort zones and grow, not put a chip in our heads or a pill in our throats that eliminates the possibility of feeling certain sensations.
There comes the point where our humanness needs to be preserved. The invention of Smartphones has taken away a lot of opportunities for face-to-face interaction, and there is plenty of evidence to suggest that anxiety and depression disorders are caused by these devices, especially through social media use.
I am interested to hear other points on this matter because I know some people have different experiences with anxiety and depression than me. One thing I’ve always loved is hearing other people’s stories about how their anxiety or depression changed their lives. It usually starts with a valley and turns into a peak. While this can differ from case to case, two people rarely have identical stories when talking about their experiences. They also, frequently, are different from one case to the next because of how we obtained anxiety or depression. Some get it through abuse, and some get it from other forms of trauma when their brain is developing.
Neuralink is yet another brilliant idea from Elon Musk. It will hopefully change the way certain neurological diseases are treated and can provide some insight into what causes these medical conditions. However, there has to be boundaries and taking emotions and psychological responses away, in my opinion, is not the right thing to do. To quote Dr. Martin Luther King Jr., “Darkness cannot drive out darkness; only light can do that.”
I use this newsletter to share my thoughts on what is going on in the Tesla world. If you want to talk to me directly, you can email me or reach me on Twitter. I don’t bite, be sure to reach out!
-
Tesla CEO Elon Musk took to his social media platform X on Thursday night to deny a ridiculous rumor regarding the sale of the company’s Chinese vehicle production plant, Gigafactory Shanghai.
On Thursday, the Wall Street Journal, citing sources familiar with the matter, claimed in a scathing new report that Tesla was exploring a potential sale of the entire China business in an effort to help bolster a potential merger between SpaceX and Tesla.
Musk immediately denied the rumor not once but twice, initially calling it “fake news,” and then calling it “absurdly fake news” in a separate post just a few moments later:
This is fake news
— Elon Musk (@elonmusk) July 31, 2026
The original poster of the Wall Street Journal article that Musk saw deleted the initial post sharing the headline and the rumored sale of Tesla’s China business.
This has never even come up in a discussion ever.
Absurdly fake news.
-People should assume news is fake until proven otherwise.
— Elon Musk (@elonmusk) July 31, 2026
The report seemed absolutely and unequivocally false to begin with; Tesla’s business in China is among the most important pieces of the company’s business. Not only does the factory supply vehicles for the domestic market, but also for various other markets in Asia and Europe.
China is also one of the largest automotive markets in the world, and Tesla has performed well there despite the robust competition.
The speculation regarding a Tesla and SpaceX merger has started to gain steam this year as the space exploration company went public just a month ago. There has been speculation that Musk will bridge all of his companies under one “umbrella company,” and analysts believe this could happen before the end of the decade.
The Tesla and SpaceX merger everyone is talking about is quietly building
-
This is the latest iteration of Musk’s very evident war on mainstream media. Reports regarding any of Musk’s companies are quick to get the dreaded “false” or “fake news” response from the CEO when they are unfounded.
Elon Musk
Tesla AI boss reveals how big Optimus is going to get
Tesla’s Optimus chief corrected himself on X, confirming a staggering 10 million robot production target.
![Tesla Optimus Gen 3 [Credit: Tesla]](https://www.teslarati.com/wp-content/uploads/2026/03/tesla-optimus-gen3-diner.jpg)
Tesla’s Optimus program has a new number attached to it, after Ashok Elluswamy, the executive who has run the humanoid robot program since June 2025, posted a three word correction on X Thursday, “Correction, 10 million robots.”
The line clarifies the long term annual capacity Tesla is building toward its planned second Optimus production line at Gigafactory Texas, a figure Musk has cited repeatedly since last year’s shareholder meeting.
The scale is worth noting, because ten million robots a year would mean Tesla building more units annually than most countries sell in new cars. Tesla has framed this as a second line, not the first. The buildout is happening in two phases: a roughly one million unit per year line inside Tesla’s Fremont factory, installed on the floor space vacated when Model S and Model X production ended earlier this year, and a much larger dedicated facility under construction at Giga Texas that broke ground on its first steel structure in May. That Texas facility is the one Elluswamy’s correction refers to, and is expected to reach volume production sometime in 2027.
Correction, 10 million robots https://t.co/0z4nyQNTzp
— Ashok Elluswamy (@aelluswamy) July 30, 2026
Tesla Optimus project fires up as Musk sees production line progress
Elluswamy took over Optimus from Milan Kovac last summer and has spent the months since talking up the program’s trajectory. Elon Musk has also floated the ten million figure at Tesla’s 2025 shareholder meeting.
-
Ending Model S and Model X production to make room for the first Optimus line was one of the more consequential manufacturing decisions in the company’s recent history, retiring two flagship vehicles in favor of a robot that has yet to enter mass production. Musk has previously estimated per unit production costs at $20,000 to $25,000 once Tesla reaches a million units a year, though he hasn’t said what that cost looks like at ten times the volume.
The Trump Administration today made several key moves to help with the deployment of autonomous vehicles by cutting overreaching red tape that has stifled growth and innovation for years.
The moves, which were put forth by the National Highway Traffic Safety Administration (NHTSA), aim to grant temporary exemptions to at least one company currently, although that could expand in the coming months. Additionally, it will work with organizations to develop standards and a sound but efficient regulatory landscape.
Zoox is the only company mentioned explicitly by the Trump Administration in its press release announcing the new terms today. They will receive a temporary two-year exemption that will allow the commercial deployment of up to 2,500 vehicles annually for two years.
There is a potential exemption for Robomart, Inc., which “requests a temporary exemption from certain FMVSS No. 500 requirements for a low-speed vehicle operated by an ADS without a human driver onboard. NHTSA will publish a separate notice seeking public comment on its merits once the initial evaluation is complete,” the agency said.
Here are the five new terms that Secretary Sean Duffy has implemented through the NHTSA today:
- Allow Zoox to commercially deploy its robotaxis through a temporary exemption.
This temporary exemption will allow the commercial deployment of up to 2,500 vehicles annually for two years, subject to an enhanced, adaptable oversight structure that can evolve as Zoox’s technology advances. - Accelerate development of first-ever AV performance standards through a partnership with SAE Industry Technologies Consortia (ITC).
This partnership will fund a three-year, $5 million “A2SCEND” consortium, bringing together experts to gather data and accelerate creation of the first-ever AV performance standards. This project will inform a single national standard for AV safety to eliminate the patchwork regulatory landscape that has stifled innovation for years. - Publish an interim final rule that allows vehicles manufactured prior to an exemption to be eligible for a commercial deployment exemption.
This rule will modernize the application process and improve access to exemptions for innovators, including AV developers, by granting the NHTSA Administrator the discretion to apply temporary exemptions to vehicles manufactured prior to the effective date of an exemption grant. - Streamline the application process for Part 555 exemptions by updating guidance and soliciting feedback from the public.
By updating the Part 555 exemption process—which allows automakers to temporarily sell a limited number of non-compliant vehicles, primarily to test new technologies—NHTSA is aiming to create a more flexible oversight structure for exemptions and summarize recent AV framework activities, including expanded exemption pathways, streamlined crash reporting, and ongoing efforts to modernize Federal Motor Vehicle Safety Standards (FMVSS). - Establish a new Federal Docket for public feedback on NHTSA’s updated safe AV development and deployment guidance.
NHTSA is updating its technical guidance for AVs for the first time since 2017—focusing on key safety areas like emergency responder interactions, safety management systems, remote assistance, and post-crash behavior to help the industry scale up driverless deployments safely.
Additionally, the NHTSA said it has modernized some safety standards by proposing updates to:
- FMVSS 102 – Transmission shifting
- FMVSS 103/104 – Windshield defrosting and wiping
- FMVSS 110 – Tire placards
- FMVSS 135 – Braking systems
- FMVSS 101 – Controls and displays
- FMVSS 108 – Vehicle lighting
- FMVSS 111 – Mirrors and rearview display
- FMVSS 126 – Electronic stability control systems
- FMVSS 201/208 – Sun visors and warning labels
These changes aim to make the regulatory process for autonomous vehicles more streamlined and efficient, which could help the U.S. gain dominance over autonomous vehicle systems moving forward.
Tesla CEO Elon Musk denies ridiculous Gigafactory Shanghai rumor
![Tesla Optimus Gen 3 [Credit: Tesla]](https://www.teslarati.com/wp-content/uploads/2026/03/tesla-optimus-gen3-diner-80x80.jpg)
Tesla AI boss reveals how big Optimus is going to get
